Literature DB >> 29544121

Myeloid derived-suppressor cells: their role in cancer and obesity.

Suzanne Ostrand-Rosenberg1.   

Abstract

Myeloid-derived suppressor cells (MDSC) are present in most individuals with cancer where they inhibit adaptive and innate antitumor immunity and are an obstacle to cancer immunotherapies. Chronic inflammation is characteristic of adipose tissue and is a risk factor for the onset and progression of cancer in obese individuals. Because MDSC accumulate in response to inflammation, it has been hypothesized that one of the mechanisms by which obesity promotes malignancy is through the induction of MDSC. This article reviews the data supporting this hypothesis, the role of leptin and fatty acid metabolism in the induction of MDSC, and the surprising finding that although MDSC promote tumor progression, they are protective against some of the metabolic dysfunction associated with obesity.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29544121      PMCID: PMC5943167          DOI: 10.1016/j.coi.2018.03.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  49 in total

1.  Leptin signaling protects NK cells from apoptosis during development in mouse bone marrow.

Authors:  Cherry Kam Chun Lo; Queenie Lai Kwan Lam; Min Yang; King-Hung Ko; Lingyun Sun; Rui Ma; Shengjun Wang; Huaxi Xu; Sidney Tam; Chang-You Wu; Bo-Jiang Zheng; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2009-10       Impact factor: 11.530

2.  Increased monocytic CD14⁺HLADRlow/- myeloid-derived suppressor cells in obesity.

Authors:  Yi Bao; Juanfen Mo; Lingjuan Ruan; Guo Li
Journal:  Mol Med Rep       Date:  2014-11-11       Impact factor: 2.952

3.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 4.  Obesity, Inflammation, and Cancer.

Authors:  Tuo Deng; Christopher J Lyon; Stephen Bergin; Michael A Caligiuri; Willa A Hsueh
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

5.  Leptin Regulation of Immune Responses.

Authors:  Caitlin Naylor; William A Petri
Journal:  Trends Mol Med       Date:  2016-01-14       Impact factor: 11.951

6.  Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway.

Authors:  Dehong Yan; Quan Yang; Maohua Shi; Limei Zhong; Changyou Wu; Tao Meng; Huiyong Yin; Jie Zhou
Journal:  Eur J Immunol       Date:  2013-08-29       Impact factor: 5.532

Review 7.  Obesity and cancer: inflammation bridges the two.

Authors:  Ryan Kolb; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Curr Opin Pharmacol       Date:  2016-07-16       Impact factor: 5.547

8.  Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.

Authors:  Virginia K Clements; Tiha Long; Ramses Long; Chas Figley; Daniel M C Smith; Suzanne Ostrand-Rosenberg
Journal:  J Leukoc Biol       Date:  2018-01-03       Impact factor: 4.962

9.  Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells.

Authors:  Amir A Al-Khami; Liqin Zheng; Luis Del Valle; Fokhrul Hossain; Dorota Wyczechowska; Jovanny Zabaleta; Maria D Sanchez; Matthew J Dean; Paulo C Rodriguez; Augusto C Ochoa
Journal:  Oncoimmunology       Date:  2017-06-30       Impact factor: 8.110

10.  Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.

Authors:  T Gainsford; T A Willson; D Metcalf; E Handman; C McFarlane; A Ng; N A Nicola; W S Alexander; D J Hilton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

View more
  45 in total

Review 1.  Second malignancies in multiple myeloma; emerging patterns and future directions.

Authors:  Kylee Maclachlan; Benjamin Diamond; Francesco Maura; Jens Hillengass; Ingemar Turesson; C Ola Landgren; Dickran Kazandjian
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-11       Impact factor: 3.020

2.  Lipid Metabolism in Tumor-Associated Myeloid-Derived Suppressor Cells.

Authors:  Wei Liu; Hua Song; Xiaojing Li; Deshan Ren; Shuai Ding; Yan Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Obesity as an immune-modifying factor in cancer immunotherapy.

Authors:  Robert J Canter; Catherine T Le; Johanna M T Beerthuijzen; William J Murphy
Journal:  J Leukoc Biol       Date:  2018-05-15       Impact factor: 4.962

4.  miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.

Authors:  Xingju Zhang; Fei Li; Ying Tang; Qinglan Ren; Bin Xiao; Ying Wan; Shan Jiang
Journal:  Oncogene       Date:  2020-08-27       Impact factor: 9.867

Review 5.  Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment.

Authors:  Suzanne Ostrand-Rosenberg; Daniel W Beury; Katherine H Parker; Lucas A Horn
Journal:  Cancer Immunol Immunother       Date:  2019-09-09       Impact factor: 6.968

Review 6.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.

Authors:  Fang Wei; Dan Wang; Junyuan Wei; Niwen Tang; Le Tang; Fang Xiong; Can Guo; Ming Zhou; Xiaoling Li; Guiyuan Li; Wei Xiong; Shanshan Zhang; Zhaoyang Zeng
Journal:  Cell Mol Life Sci       Date:  2020-07-11       Impact factor: 9.261

7.  The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.

Authors:  Benjamin T Himes; Timothy E Peterson; Tristan de Mooij; Luz M Cumba Garcia; Mi-Yeon Jung; Sarah Uhm; David Yan; Jasmine Tyson; Helen J Jin-Lee; Daniel Parney; Yasmina Abukhadra; Michael P Gustafson; Allan B Dietz; Aaron J Johnson; Haidong Dong; Rachel L Maus; Svetomir Markovic; Fabrice Lucien; Ian F Parney
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

Review 8.  Myeloid-derived suppressor cells (MDSC): When good intentions go awry.

Authors:  Maria Dulfary Sanchez-Pino; Matthew J Dean; Augusto C Ochoa
Journal:  Cell Immunol       Date:  2021-02-04       Impact factor: 4.868

Review 9.  Targeting CSPG4 for isolation of melanoma cell-derived exosomes from body fluids.

Authors:  S Ferrone; T L Whiteside
Journal:  HNO       Date:  2020-02       Impact factor: 1.284

10.  Association between cellular immune response and spleen weight in mice with hepatocellular carcinoma.

Authors:  Wei Jiang; Yu Li; Shuqun Zhang; Guangyao Kong; Zongfang Li
Journal:  Oncol Lett       Date:  2021-06-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.